39. Anti-Spike Monoclonal Antibody Therapy for Kidney Transplant Recipients with COVID-19

BACKGROUND: Organ transplant recipients may not mount an adequate immune response to COVID-19 infection, and therefore may benefit greatly from passive immunization with anti-spike monoclonal antibodies (mAb), which have been shown to decrease hospitalization rates in the general outpatient populati...

Descripción completa

Detalles Bibliográficos
Autores principales: Hardesty, Anna, Klein, Elizabeth, Vieira, Kendra, Farmakiotis, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Oral Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644697/
http://dx.doi.org/10.1093/ofid/ofab466.039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644697/
http://dx.doi.org/10.1093/ofid/ofab466.039

Ejemplares similares